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Background: The fungus of Ganoderma is a traditional medicine in Asia with a variety of pharmacological functions
including anti-cancer activities. We have purified an extracellular heteropolysaccharide fraction, PS-F2, from the
submerged mycelia culture of G. formosanum and shown that PS-F2 exhibits immunostimulatory activities. In this
study, we investigated the molecular mechanisms of immunostimulation by PS-F2.
Results: PS-F2-stimulated TNF-α production in macrophages was significantly reduced in the presence of
blocking antibodies for Dectin-1 and complement receptor 3 (CR3), laminarin, or piceatannol (a spleen tyrosine
kinase inhibitor), suggesting that PS-F2 recognition by macrophages is mediated by Dectin-1 and CR3 receptors.
In addition, the stimulatory effect of PS-F2 was attenuated in the bone marrow-derived macrophages from
C3H/HeJ mice which lack functional Toll-like receptor 4 (TLR4). PS-F2 stimulation triggered the phosphorylation
of mitogen-activated protein kinases JNK, p38, and ERK, as well as the nuclear translocation of NF-κB, which all
played essential roles in activating TNF-α expression.
Conclusions: Our results indicate that the extracellular polysaccharides produced by G. formosanum stimulate
macrophages via the engagement of multiple pattern-recognition receptors including Dectin-1, CR3 and TLR4,
resulting in the activation of Syk, JNK, p38, ERK, and NK-κB and the production of TNF-α.
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In Asian traditional medicine, the fungus of Ganoderma
(also called Reishi or Ling-Zhi) has been used, for thou-
sands of years, as a health promoting supplement to
treat various diseases [1], but not until recently have
the pharmacologically active components in Ganoderma
been purified and characterized [2,3]. Various pharmaco-
logically active substances, including polysaccharides,
triterpenoids, alkaloids, steroids, amino acids, proteins,
nucleosides, and nucleotides have been isolated from
Ganoderma [2-4]. The polysaccharide, protein, and* Correspondence: cjchen1@ntu.edu.tw
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reproduction in any medium, provided the ortriterpenoid components of Ganoderma have anti-tumor
properties, which may function via their immunomodu-
latory activities [5]. Among the bioactive components,
polysaccharides extracted from the fruiting bodies, or
mycelia, of Ganoderma exhibit immunostimulatory
activities on dendritic cells [6,7], monocytes/macrophages
[8-10], neutrophils [11,12], and NK cells [13].
The innate immune system serves as the first line
of defense against microbial infection, and functions
primarily via the recognition of conserved microbial
structures (the pathogen-associated molecular patterns
or PAMPs) by pattern recognition receptors (PRRs)
expressed on innate immune cells such as macrophages,
neutrophils, and dendritic cells [14]. Among various
PRRs identified to date, Toll-like receptors (TLRs) aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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identified in humans and mice and each of which is
specific for different PAMPs. TLRs are type I transmem-
brane proteins which have conserved N-terminal leu-
cine-rich repeats and a cytoplasmic Toll/IL-IL-1R
homology (TIR) domain. Upon activation by respective
PAMPs, TLRs recruit a set of TIR domain-containing
adaptor molecules and initiate signaling cascades that
lead to the activation of NF-κB and IRFs and the expres-
sion of proinflammatory cytokines, chemokines, and
type I interferons [15]. Many PAMPs are exposed and
structurally conserved microbial surface structures, such
as the outer membrane lipopolysaccharides (LPS) and
cell wall peptidoglycan of bacteria, and components of
the fungal cell wall. Gram-negative bacterial LPS is deliv-
ered to TLR4 via the accessory proteins LBP, CD14 and
MD-2, and the activated TLR4 recruits four adaptor
molecules: TIRAP, MyD88, TRAM, and TRIF. TLR4
interacts with TIRAP and MyD88 at the plasma mem-
brane, and MyD88 further recruits IRAKs, TRAF6, and
the TAK1 complex, resulting in the activation of NF-κB
and mitogen-activated protein (MAP) kinases. At a later
stage, TLR4 is endocytosed and delivered to intracellular
vesicles, where it forms a complex with TRAM and
TRIF, leading to IRF3 activation and the late-phase acti-
vation of NF-κB and MAPKs [15].
The fungal cell wall is predominantly composed of
glycoprotein’s and carbohydrate polymers, including β-
glucan, chitin and mannan, and, in most yeasts and
molds, the cell wall polysaccharides have a core skeleton
composed of branched β-1,3-glucans [16]. These cell
wall components may serve as PAMPs and be recog-
nized by a variety of host PRRs. TLR4 recognizes man-
nans expressed by Saccharomyces cerevisiae and
Candida albicans [17]. Several receptors recognize β-
glucan, including the C-type lectin receptor Dectin-1
[18], complement receptor 3 (CR3) [19], scavenger
receptors [20], lactosylceramide [21], TLR2 [22], and
TLR4 [6,9]. Of these Dectin-1 plays a major role in β-
glucan recognition and control of fungal infection [23].
Activation of Dectin-1 by β-glucan leads to the initiation
of spleen tyrosine kinase (Syk)- and caspase recruitment
domain family member 9 (CARD9)-dependent signaling
cascades, resulting in phagocytosis, respiratory burst, the
activation of NF-κB and NFAT, and the expression of
pro-inflammatory cytokines [24]. Dectin-1 can recognize
the cell wall polysaccharides of various fungal species, in-
cluding Saccharomyces cerevisiae, Candida albicans, Coc-
cidiodes posadasii, Pneumocystis carinii, Aspergillus
fumigatus, and Ganoderma lucidum [25,26]. CR3 (Mac-1,
CD11b/CD18) was the first receptor shown to recognize
β-glucan via a distinct lectin domain [19,27,28]. CR3 ac-
tivation by β-glucan triggers a downstream signaling in-
volving Syk and phosphatidylinositol 3-kinase, leadingto enhanced phagocyte killing of iC3b-opsonized tumor
cells [29].
Ganoderma formosanum is a native species of
Ganoderma, first isolated in Taiwan two decades ago.
We previously established a submerged mycelia culture
system of G. formosanum and purified the extracellular
polysaccharides in the culture broth. The polysacchar-
ides are mainly composed of D-mannose, D-galactose
and D-glucose, and we showed that the major polysac-
charide fraction PS-F2 could stimulate the activation of
macrophages and protect mice against Listeria monocy-
togenes infection [30]. In this study, we further investi-
gate the molecular mechanism of macrophage activation
by PS-F2, and our results demonstrate that PS-F2 recog-
nition is mediated by Dectin-1, CR3 and TLR4 on
macrophages, leading to the activation of multiple
signaling cascades involving Syk, JNK, p38, ERK and
NK-κB in macrophages.
Results and discussion
Role of Dectin-1 and CR3 in PS-F2 stimulation
To elucidate the mechanisms of PS-F2-stimulated
macrophage activation, we first investigated what recep-
tor(s) on macrophages could mediate the recognition
of PS-F2. We hypothesized that PS-F2 functions as a
fungal PAMP and interacts with certain sugar-binding
PRR(s) on macrophages. C-type lectin receptors (CLRs)
expressed on myeloid cells can recognize the carbohy-
drate structures on microorganisms [31]. Since mannose
is the major carbohydrate component in PS-F2 [30], it is
possible that a CLR with mannose specificity may medi-
ate this interaction. However, the addition of mannan
to the culture did not affect PS-F2-induced macrophage
activation (Figure 1A), indicating that the PS-F2-binding
receptor(s) on macrophages may not recognize the
mannose moieties in PS-F2. Dectin-1 is a member
of group V CLRs and serves as a PRR to sense the
β-glucan in fungal cell wall [18]. To determine if
Dectin-1 plays a role in PS-F2 recognition, RAW264.7
cells were stimulated with PS-F2 or zymosan in the pres-
ence of anti-Dectin-1 blocking antibodies. As expected,
the stimulatory activity of zymosan was blocked by the
antibodies (see Additional file 1). Anti-Dectin-1 anti-
bodies also significantly suppressed PS-F2-stimulated
TNF-α production (Figure 1B), indicating that PS-F2 sti-
mulates macrophages, in part, via Dectin-1. It is likely
that Dectin-1 recognizes β-glucan in PS-F2. However,
since ligands other than β-glucan may also bind Dectin-1
[32], it remains possible that Dectin-1 may interact with
other unique polysaccharide structures in PS-F2.
CR3 is another receptor which recognizes fungal β-
glucan [19], and the interaction is via a cation-independent
lectin site located C-terminal to the I-domain of CD11b,
which can be blocked by anti-CD11b mAb M1/70 [28].
Figure 1 PS-F2 stimulates macrophage activation via Dectin-1 and CR3-mediated pathways. RAW264.7 cells were pre-incubated with or
without mannan (A), anti-Dectin-1 antibody (2 μg/ml) (B), anti-CR3 antibody (C), or laminarin (D) for 1 h and stimulated with PS-F2 (10 μg/ml) or
LPS (0.2 μg/ml) in the presence or absence of various reagents as indicated for additional 20 h. Cells left untreated, treated with isotype rat IgG2a
antibody (B), or isotype rat IgG2b antibody (C) served as controls. TNF-α concentrations in the culture fluids were determined by ELISA (n = 3).
Data shown are representative of 3 or more experiments. * P < 0.05, **P < 0.01 versus PS-F2 stimulation alone in (D).
Wang et al. BMC Complementary and Alternative Medicine 2012, 12:119 Page 3 of 10
http://www.biomedcentral.com/1472-6882/12/119Indeed, we found that this mAb was able to block
zymosan-stimulated TNF-α production in macrophages
(see Additional file 1). To determine if CR3 is involved in
the recognition of the G. formosanum polysaccharides, PS-
F2 stimulation was performed in the presence of M1/70
blocking antibodies for CR3. Results showed that TNF-α
production was blocked by the anti-CR3 antibody in a
dose-dependent way (Figure 1C). Dectin-1 and CR3 are,
therefore, both involved in recognition of PS-F2. Laminarin
is the β-glucan from brown algae and non-stimulatory, but
blocks the stimulatory effects of various fungal β-glucans
[33]. When stimulation was performed in the presence of
laminarin, results showed that laminarin markedly and
specifically inhibited PS-F2-induced macrophage activation
(Figure 1D); in contrast, laminarin had no effect on LPS
stimulation. The strong inhibition of PS-F2 stimulation by
laminarin suggests that PS-F2 interaction with certain
β-glucan-binding receptor(s) is responsible for macro-
phage activation. We have tried to determine whether
the stimulatory function of PS-F2 is provided by β-glucan
by treating PS-F2 with laminarinase; however the laminari-
nase of commercial source contained certain contaminants
which also stimulated the activation of macrophages. Over-
all, these data suggest that the β-glucan receptors Dectin-1
and CR3 both play important roles in the recognition
of PS-F2.Role of TLR4 in PS-F2 stimulation
Previous studies report that, in addition to Dectin-1 and
CR3, TLR4 also recognizes fungal β-glucans, in particu-
lar the polysaccharides extracted from G. lucidum [6,9].
Although the polysaccharides purified from the sub-
merged culture of G. formosanum appear distinct in
sugar compositions from the polysaccharides extracted
from G. lucidum [30,34], we also examined whether
TLR4 plays a role in PS-F2 recognition. C3H/HeJ mice
have a spontaneous mutation in the TLR4 gene and are
thus resistant to endotoxin [35]. Upon PS-F2 stimula-
tion, BMDMs from C3H/HeJ mice produced a signifi-
cantly lower level of TNF-α compared with the BMDMs
from wild-type C3H/HeN mice (Figure 2A). In contrast,
the BMDMs from these two mouse strains showed
similar responses to poly (I:C) (a TLR3 ligand) stimula-
tion, indicating that PS-F2 specifically stimulates macro-
phages via TLR4. Consistent with the results in
Figure 1D, addition of laminarin could suppress PS-F2-
stimulated TNF-α production in both wild-type and
TLR4-mutant BMDMs, and the stimulatory effect was
almost completely eliminated in TLR4-mutant BMDMs
when laminarin was present (Figure 2A). Although TLR2
has been reported to recognize fungal polysaccharides
[22,36], it is not responsible for recognizing PS-F2 since
BMDMs derived from wild-type and TLR2−/− mice
Figure 2 The role of TLR4 in PS-F2-induced macrophage
activation. (A) BMDMs from C3H/HeN (wild type) and C3H/HeJ
(TLR4 mutant) mice were pre-incubated with or without laminarin
(0.3 mg/ml) or piceatannol (25 μM) for 1 h and stimulated with
PS-F2 in the presence or absence of laminarin or piceatannol for
20 h. BMDMs left untreated or stimulated with poly (I:C) (10 μg/ml)
served as controls. TNF-α concentrations in the culture fluids were
determined by ELISA (n = 3). (B) RAW264.7 cells were stimulated
with LPS (0.5 μg/ml) or PS-F2 (15 μg/ml) for 5 h (first stimulation),
and after medium removal and washing, fresh media containing LPS
(0.5 μg/ml) or PS-F2 (15 μg/ml) were added as indicated (second
stimulation). At 20 h after second stimulation, TNF-α concentrations
in the culture fluids were determined by ELISA (n = 3). Data shown
are representative of 3 or more experiments. **P < 0.01.
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Additional file 2). Collectively, our data demonstrate that
Dectin-1, CR3 and TLR4 are the three major receptors
involved in the detection of PS-F2 by macrophages.
Although the carbohydrate structure in PS-F2 that is
recognized by TLR4 remains to be determined, it
appears that TLR4 can detect carbohydrate-containing
PAMPs. Several studies also report that polysaccharides
from various fungal species, including G. lucidum,
stimulate immune cell activation via TLR4 [6,9,36-38].
In addition, TLR4 also serves as a receptor for botanical
polysaccharides which exhibit immunostimulatory activ-
ities [39]. Using a carbohydrate-receptor binding assay, a
recent study showed that the polysaccharides extractedfrom G. lucidum interacted with a number of innate
immune receptors, including Dectin-1, DC-SIGN,
Langerin, Kupffer cell receptor, macrophage mannose
receptor, TLR2 and TLR4 [40]. Based on our and others’
findings, it is clear that the innate immune cells can
utilize multiple PRRs for recognition of the heteropoly-
saccharides in fungal cell walls. Different cell types may
have different expression patterns of various PRRs,
which would determine the outcome of polysaccharide
stimulation. We have routinely observed that PS-F2
stimulated a significantly higher level of TNF-α pro-
duction in RAW264.7 cells than in BMDMs. Besides the
difference in cell origins (cell line vs. primary cell), we
speculate that the relative expression levels of various
PRRs may be different between these two types of
macrophages, resulting in the difference in response to
PS-F2 stimulation.
Prior exposure of innate immune cells to LPS causes
them to become refractory to subsequent LPS challenge,
a phenomenon called “LPS tolerance” [41]. To test the
possibility that prior LPS or PS-F2 exposure would
make macrophages refractory to subsequent PS-F2
stimulation, RAW264.7 cells were stimulated with LPS
or PS-F2, then subjected to secondary stimulation with
LPS or PS-F2 5 hours later. As expected, LPS-exposed
macrophages did not show further TNF-α production
after second LPS challenge (Figure 2B). However, if cells
were pretreated with LPS or PS-F2, subsequent PS-F2
stimulation could further increase the production of
TNF-α (Figure 2B). These results indicate that, although
TLR4 is one of the receptors for PS-F2, the “LPS toler-
ance” phenomenon does not occur upon PS-F2 stimula-
tion, which may be due the activation of Dectin-1 and
CR3. The data also excluded the possibility that the
observed immunostimulatory activity of PS-F2 was
caused primarily by LPS contamination in the samples.
PS-F2-stimulated TNF-α production in macrophages
requires the activation of MAPKs and NF-κB
The MAPKs (ERK, JNK and p38) play critical roles in the
downstream signaling of various PRRs including TLRs
and Dectin-1 [42]. To characterize PS-F2-stimulated sig-
naling pathways that lead to TNF-α production in RAW
264.7 cells, PS-F2 stimulation resulting in the phosphoryl-
ation and activation of MAPKs was first evaluated. Using
antibodies specific for the phosphorylated JNK, p38 and
ERK in Western blotting, protein phosphorylation was
detected, starting at 20 min after PS-F2 stimulation
(Figure 3A and 3B). To determine if activation of MAPKs
plays a role in PS-F2-induced TNF-α production,
RAW264.7 cells were stimulated with PS-F2 in the pres-
ence of MAPK inhibitors: UO126 (ERK inhibitor),
SB202190 (p38 inhibitor), and SP600125 (JNK inhibitor).
We have confirmed that theses inhibitors were effective
Figure 3 (See legend on next page.)
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Figure 3 Activation of MAPKs (JNK, ERK, and p38) is required for PS-F2-stimulated TNF-α production in macrophages. (A) RAW264.7
cells were untreated or stimulated with PS-F2 (8 μg/ml), and total cell lysates were prepared at different times after stimulation. Equal amounts
of cell lysates from the samples were subjected to Western blotting with antibodies specific for phosphorylated and total JNK, ERK and p38.
(B) Signals in panel A were quantified by densitometric analysis, and phospho-specific signals were normalized against total protein signals. Bars
indicate the fold changes of phosphorylated MAPK amounts at indicated time points over those at 0 min (n = 3). (C) RAW264.7 cells were
pre-incubated with or without UO126 (ERK inhibitor), SB202190 (p38 inhibitor), or SP600125 (JNK inhibitor) for 30 min and stimulated with PS-F2
(15 μg/ml) for additional 20 h in the presence or absence of inhibitors. Cells left untreated or treated with inhibitors alone served as controls.
TNF-α levels in the culture fluids were determined by ELISA (n = 3). Data shown are representative of 3 or more experiments. *P < 0.05,
**P < 0.01 versus PS-F2 stimulation alone in (C).
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Additional file 3). As shown in Figure 3C, TNF-α pro-
duction was significantly inhibited by U0126, SB202190,
and SP600125, indicating that PS-F2-triggered activa-
tion of JNK, p38 and ERK all are involved in signaling
for TNF-α production in RAW 264.7 cells. Besides
MAPK signaling cascades, stimulation of various PRRs
also leads to the degradation of I-κB by proteasome,
which then allows NF-κB to translocate into the nucleus
and activate the expression of proinflammatory cyto-
kines. To determine whether PS-F2 stimulation could
activate NF-κB, the levels of I-κB and NF-κB p65 sub-
unit were assessed in the cytosolic and nuclear fractions,
respectively. Upon PS-F2 stimulation, a transient (20–
50 min), but clear, reduction of I-κB in the cytosol and a
concomitant increase in NF-κB in the nucleus were
noted (Figure 4A and 4B), indicating nuclear transloca-
tion and activation of NF-κB. We next determined
whether the translocated NF-κB played a role in activat-
ing TNF-α expression by using the proteasome inhibitor
MG132 and the NF-κB-specific inhibitor 481406. As a
positive control, we found that both inhibitors effect-
ively suppressed LPS-stimulated TNF-α production in
RAW264.7 cells (see Additional file 3). When cells were
treated with MG132 or 481406, PS-F2-stimulated TNF-α
production was significantly reduced (Figure 4C). These
results indicate that upon PS-F2 stimulation, both MAPK
and NF-κB signaling pathways are activated and play
important roles in the activation of TNF-α expression.
Syk mediates PS-F2-stimulated signaling and
TNF-α production
Our data indicate that Dectin-1, CR3 and TLR4 could
all serve as receptors for PS-F2. Syk kinase is a common
signaling molecule downstream of Dectin-1 and CR3
[43], and we found that PS-F2-stimulated TNF-α pro-
duction in macrophages was specifically and significantly
suppressed by the Syk inhibitor piceatannol (Figure 5A
and 2A). To further determine the contribution of
Dectin-1, CR3 and TLR4 to downstream signaling, we
examined whether the activation of MAPKs and NF-κB
are regulated by Syk. Blocking Syk signaling by piceatan-
nol prevented I-κB degradation and ERK phosphoryl-
ation but, in contrast, the phosphorylation of p38 andJNK was not affected (Figure 5B). These results indi-
cate that, upon PS-F2 stimulation, Dectin-1 and CR3-
mediated Syk activation leads to ERK phosphorylation
and NF-κB activation, while TLR4 may contribute to the
activation of p38, JNK, ERK and NF-κB. Similar to our
observation, Syk signaling is important in zymosan-
induced ERK activation in dendritic cells [42] (Figure 6).
Conclusion
In this study, we elucidate the molecular mechanism
of macrophage activation by the heteropolysaccharide PS-
F2 purified from the submerged culture of G. formosa-
num. Our data demonstrate that PS-F2 stimulates the ac-
tivation of macrophage via the engagement of Dectin-1,
CR3, and TLR4. The activation of these PRRs turned on
the downstream signaling cascades involving Syk, JNK,
p38, ERK and NK-κB, resulting in macrophage activation
and TNF-α production. Together with the previous find-
ing that PS-F2 could stimulate the activation of innate
immune response in vivo and protect mice against Listeria
monocytogenes infection [30], our results indicate that the
extracellular polysaccharides of G. formosanum have the
potential to be used as immunomodulatory agents in the
treatment of infectious and malignant diseases.
Methods
Cell cultures and animals
Murine macrophage RAW264.7 cells were maintained
as previously described [30]. Bone marrow-derived
macrophages (BMDMs) were obtained by culturing bone
marrow cells in DMEM (HyClone, UT, USA) supple-
mented with 10% fetal bovine serum (FBS) (Biological
Industries, Beit-Haemek, Israel) and 30% L cell-
conditioned medium for 7 days. C57BL/6 and C3H/HeN
mice (6–8 weeks old) were purchased from the National
Laboratory Animal Center (Taipei, Taiwan). C3H/HeJ
(TLR4 mutant) mice were kindly provided by Dr. Zao-
dung Ling (National Health Research Institutes, Taiwan).
TLR2−/− mice were kindly provided by Dr. Shu-Mei
Liang (Academia Sinica, Taiwan). All animal studies
were approved by the Institute Animal Care and Use
Committee of National Taiwan University, and all mice
were kept in the animal facilities of the College of Life
Science at National Taiwan University.
Figure 4 NF-κB activation is required for PS-F2-stimulated TNF-α production in macrophages. (A) RAW264.7 cells were untreated or
stimulated with PS-F2 (8 μg/ml), and the cytosolic and nuclear fractions were prepared at indicated time points. Equal amounts of protein from
the cytosolic fractions were subjected to Western blotting for I-κB and actin, and equal amounts of protein from the nuclear fractions were
subjected to Western blotting for NF-κB and HDAC1. (B) Signals in panel A were quantified by densitometric analysis. I-κB signals were
normalized against actin signals, and NF-κB signals were normalized against HDAC1 signals. Bars indicate the fold changes of I-κB and NF-κB
amounts at indicated time points over those at 0 min (n = 3). (C) RAW264.7 cells were pre-incubated with or without MG132 or 481408 (NF-κB
activation inhibitors) for 30 min and stimulated with PS-F2 (15 μg/ml) for additional 20 h in the presence or absence of inhibitors. Cells left
untreated or treated with inhibitors alone served as controls. TNF-α levels in the culture fluids were determined by ELISA (n = 3). Data shown are
representative of 3 or more experiments. **P < 0.01 versus PS-F2 stimulation alone in (C).
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Figure 5 Role of Syk activation in PS-F2-stimulated TNF-α
production in macrophages. (A) RAW264.7 cells were untreated or
treated with piceatannol (10 and 25 μM) for 1 h and stimulated with
PS-F2 (10 μg/ml) or poly (I:C) (10 μg/ml) for additional 20 h. Cells
left unstimulated or stimulated with poly (I:C) served as controls.
TNF-α concentrations in the culture fluids were determined by ELISA
(n = 3). Data shown are representative of 3 or more experiments.
(B) RAW264.7 cells were pre-incubated with or without piceatannol
(25 μM) for 1 h and stimulated with PS-F2 (8 μg/ml) in the presence
or absence of piceatannol. Cells left untreated served as controls.
At 30 min after stimulation, cytosolic fractions and total cell lysates
were prepared. Equal amounts of protein from the cytosolic
fractions were subjected to Western blotting for I-κB and actin,
and equal amounts of total cell lysates were subjected to Western
blotting for phosphorylated and total JNK, ERK and p38. Changes
in the I-κB signals (normalized against actin signals) and the
phospho-specific signals (normalized against the total protein
signals) are expressed as fold changes over the untreated group
signals and indicated below each lane. * P < 0.05, **P < 0.01 versus
PS-F2 stimulation alone in (A).
Figure 6 Proposed mechanism for PS-F2-stimulated
macrophage activation. PS-F2 stimulates the activation of
macrophage via the engagement of Dectin-1, CR3, and TLR4. The
activation of these PRRs turned on the downstream signaling
cascades involving Syk, JNK, p38, ERK and NK-κB, resulting in
macrophage activation and TNF-α production.
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The major polysaccharide fraction PS-F2 was purified
from the submerged culture of G. formosanum as previ-
ously described [30], and the endotoxin level was deter-
mined to be less than 0.3 EU/mg by the Limulus
Amebocytes Lysate (LAL) test (Associates of Cape CodInc., East Falmouth, MA, USA). LPS (from E. coli O111:
B4), laminarin, mannan, and polymyxin B were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA).
SB202190, 481406, U0126, SP600125, and piceatannol
were purchased from Calbiochem (Darmstadt, Germany).
Poly (I:C) was purchased from InvivoGen (San Diego,
CA, USA). Anti-CR3 mAb (M1/70), rat IgG2a and rat
IgG2b isotype control antibodies were purchased from
eBioscience (San Diego, CA, USA). Anti-Dectin-1 mAb
(218820) was purchased from R&D Systems (Minneap-
olis, MN, USA). All other chemicals were purchased
from commercial sources at the highest purity available.
Cytokine production analysis
RAW264.7 cells grown in 96-well plates (1 × 105 cells/
well) were treated with polysaccharide samples, LPS or left
untreated for 20 h, and mouse TNF-α levels in the culture
medium were determined by ELISA (eBioscience). In
some experiments, cells were pre-treated with various
inhibitors or blocking antibodies for 30 min or 1 h, as
indicated in the figure legends, prior to the addition of
PS-F2.
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To prepare whole cell lysates for MAPK phosphorylation
analysis, RAW 264.7 cells plated in 6-cm dishes (2 × 106
cells) were pre-incubated in serum-free DMEM for 2 h
before stimulated with PS-F2 (8 μg/ml). At various time
after stimulation, whole cell lysates were prepared by
treating cells with 200 μl of SDS-PAGE sample buffer
(62.5 mM Tris–HCl, 2% SDS, 20% glycerol, 10% 2-
mercatoethanol, pH 6.8). To prepare cytoplasmic and
nuclear extracts, cells were harvested and resuspended
in 150 μl of hypotonic buffer (10 mM HEPES, pH 7.9,
10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM
DTT, 0.5 mM PMSF) and incubated on ice for 15 min.
The samples were then mixed with 10 μl of 10% NP-40
and centrifuged at 16,000 × g for 30 sec. The supernatant
representing the cytosolic fraction was collected, and the
pellet containing the nuclei was resuspended in 50 μl of
nuclear extract buffer (20 mM HEPES, pH 7.9, 0.4 M
NaCl, 1 mM EDTA, 0.1 mM EGTA, 1 mM DTT,
0.5 mM PMSF) and incubated at 4°C for 15 min with
vigorous shaking. After centrifugation at 16,000 × g for
5 min, the supernatant representing the nuclear fraction
was collected and stored at −20°C.
Western blot analysis
Cell lysates in SDS-PAGE sample buffer were heated
at 95°C for 5 min, separated by 12.5% SDS-PAGE,
and transferred to a nitrocellulose membrane. The mem-
brane was blocked with 5% bovine serum albumin in
Tris-buffered saline containing 0.05% Tween 20 (TBST)
and incubated with primary antibodies specific for JNK,
p38, ERK, phospho-JNK, phospho-p38, phospho-ERK,
NF-κB, I-κB (Cell Signaling, Danvers, MA, USA), β-actin
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), or
histone deacetylase 1 (HDAC1) (Upstate Biotechnology,
Waltham, MA, USA) at 4°C for overnight. The mem-
brane was then incubated with horseradish peroxidase-
conjugated secondary antibodies and visualized with an
enhanced chemiluminescence kit (VisGlow, Taiwan) and
a chemiluminescence imaging system (UVP Autochemi,
Upland, CA, USA). Densitometric analysis of band in-
tensities was performed using the ImageJ software (Na-
tional Institutes of Health).
Statistical analysis
Statistical analysis was performed using an unpaired,
two-tailed Student's t-test and a P < 0.05 was considered
significant. Data are reported as mean and SEM.
Additional files
Additional file 1: Zymosan-stimulated macrophage activation was
blocked by anti-Dectin-1 and anti-CR3 antibodies.Additional file 2: PS-F2-stimulated macrophage activation does not
require TLR2.
Additional file 3: LPS-stimulated macrophage activation was
blocked by the inhibitors of MAPK and NF-κB activation.
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